
Guilherme Nader-Marta, MD, and Erica L. Mayer, MD, MPH, discusses innovative treatments for HR-positive, HER2-negative metastatic breast cancer.

Your AI-Trained Oncology Knowledge Connection!

Guilherme Nader-Marta, MD is an advanced Clinical Fellow at Dana-Farber Cancer Institute.

Guilherme Nader-Marta, MD, and Erica L. Mayer, MD, MPH, discusses innovative treatments for HR-positive, HER2-negative metastatic breast cancer.